Skip to main content
TipRanks
Go Ultimate75% OFF

Ashland (AHT) AI Stock Analysis

0 Followers
DE:AHT

Ashland

(Frankfurt:AHT)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Cash GenerationStrong operating and free cash flow provide internal funding for investment, debt service, and shareholder returns. The recovery from negative fiscal 2025 free cash flow, combined with substantial liquidity, improves Ashland’s ability to execute initiatives through normal business volatility.
Negative Factors
Thin Net ProfitabilityVery thin net profitability leaves limited protection against operating setbacks, cost inflation, or weaker demand. The sharp contrast with fiscal 2025 losses also indicates that earnings power remains volatile, making sustained improvement dependent on consistent execution and margin recovery.

Ashland (AHT) vs. iShares MSCI Germany ETF (EWG)

-10%0%10%20%30%40%50%60%70%DE:AHT+62.49%EWG+9.37%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 3.50B
Dividend Yield
2.04%
Average Volume (3M)
433
Price to Earnings (P/E)
849.7
Beta (1Y)
0.60
Revenue Growth
-2.93%
EPS Growth
―
Country
Germany
Employees
2,800
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals - Specialty

Ashland Business Overview & Revenue Model

Company Description

Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Lif...

Ashland Earnings Call Summary

Earnings Call Date:Nov 03, 2026(Q4-2026)|% Change Since:3.08%|Next Earnings Date:Feb 02, 2027
Earnings Call SentimentPositive

The call was predominantly positive. Ashland reported broad-based sales and volume growth, strong performance in Life Sciences and Personal Care, improving Intermediates profitability, substantial cash generation, strategic initiative outperformance, and a constructive fiscal 2027 outlook. These strengths were partially offset by Specialty Additives profitability pressure from Hopewell, soft construction and energy and resources markets, foreign-currency headwinds, higher planned capital expenditures, and lower expected free cash flow conversion.

Positive Updates

Fourth-Quarter Sales and Volume Growth
Fourth-quarter sales increased 4% to $498 million, with volumes up 3% and pricing up 2%. Pricing covered cost inflation across all business units, while higher volumes, favorable mix, and pricing supported adjusted EBITDA growth.

Negative Updates

Specialty Additives Profitability Decline
Specialty Additives adjusted EBITDA declined to $20 million from $29 million, and adjusted EBITDA margin was 15.3%. The decline primarily reflected lower Hopewell productivity output and unfavorable absorption.

Company Guidance

For fiscal 2027, Ashland expects sales of $1.905 billion-$1.975 billion, adjusted EBITDA of $405 million-$435 million, ongoing free cash flow conversion greater than 40% of adjusted EBITDA, capital expenditures of up to approximately $140 million, and approximately $10 million of net productivity and manufacturing optimization benefits; globalize and innovate are targeted to contribute approximately $20 million and $45 million of incremental sales, respectively, representing a 25% increase in the combined incremental sales versus 2026, while foreign currency is expected to create headwinds of approximately $20 million-$25 million in sales and $7 million-$10 million in Adjusted EBITDA. Demand in Life Sciences and Personal Care is expected to remain resilient, Coatings and Performance Specialties are expected to build on recent commercial momentum, Hopewell output is expected to increase by about 25% roughly in fiscal 2027 with another order of magnitude similar in the following year, and over time free cash flow is expected to be greater than 50% relative to adjusted EBITDA.

Ashland Risk Analysis

Ashland disclosed 18 risk factors in its most recent earnings report. Ashland reported the most risks in the "Production" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Production - Risks related to the company’s ability to manufacture goods and services

Latest Risks Added

0 New Risks

Ashland Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

DE:AHT against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IOSPIOSP72Outperform$1.98B14.1510.42%2.23%4.73%―
FULFUL68Neutral$2.65B13.549.51%1.97%1.48%72.33%
EMNEMN65Neutral$7.44B11.4710.63%5.17%0.40%-6.58%
ESIESI62Neutral$8.03B39.147.39%0.97%39.62%-14.83%
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
SCLSCL55Neutral$1.51B349.370.36%2.38%10.02%-90.50%

* Basic Materials Sector Average

Performance Comparison

0%25%50%75%DE:AHTEMNFULIOSPSCLESIDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:AHT and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:AHTAshland Global Holdings, Inc.67.0024.0255.87%
EMNEastman Chemical Company65.0310.2818.77%
FULH.B. Fuller Company49.29-6.04-10.91%
IOSPInnospec80.399.0312.65%
SCLStepan Company66.3824.9860.33%
ESIElement Solutions33.088.3833.91%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.